- Insulet to Present at the Jefferies Global Healthcare Conference
- Insulet Reports First Quarter 2024 Revenue Increase of 23% Year-Over-Year
- Insulet’s 2023 Sustainability Report Highlights Commitment to Product Accessibility and Responsible Growth
- Insulet to Announce First Quarter 2024 Financial Results on May 9, 2024
- Insulet Appoints Ana Maria Chadwick as Chief Financial Officer
More ▼
Key statistics
As of last trade, Insulet Corp (GOV:FRA) traded at 184.95, 55.03% above the 52 week low of 119.30 set on Oct 13, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 184.95 |
---|---|
High | 184.95 |
Low | 184.95 |
Bid | 184.95 |
Offer | 189.70 |
Previous close | 186.55 |
Average volume | 26.00 |
---|---|
Shares outstanding | 70.04m |
Free float | 69.80m |
P/E (TTM) | 62.40 |
Market cap | 14.04bn USD |
EPS (TTM) | 3.21 USD |
Data delayed at least 15 minutes, as of Jun 17 2024 07:05 BST.
More ▼